Influenza virus-like particle vaccine (Novavax)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza virus-like particle vaccine (Novavax)
Drug Alias NameVLP-based trivalent seasonal influenza vaccine流感病毒样颗粒疫苗 - NovavaxNovavax trivalent vaccineSeasonal influenza VLP vaccineCadiFlu-S
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2016/01/01
Country/TerritoryUnited StatesAustraliaIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNovavax
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovavax
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB
Related LinksN/A